{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-014019","form_type":"8-K","ticker":"IVF","cik":"0001417926","company_name":"INVO Fertility, Inc.","filed_at":"2025-06-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.231036+00:00","generated_at":"2026-05-19T18:15:33.360069+00:00","sec_items":["2.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"INVO Fertility divests majority holdings in NTI, retains preferred stake and note","bullets":["Effective June 2, 2025, INVO redeemed all Series C-1 Preferred for 3,227,813 shares of NTI Class A Common, ceasing to hold NTI common.","INVO retains 6,300 shares of NTI Series A Preferred, representing 19.9% on an as-converted basis, and a $4.8M secured convertible note from NTI.","Pro forma net loss improves: Q1 2025 from $17.4M to $16.2M; FY 2024 from $9.1M to $5.7M after removing NTI operations.","The divestiture removes NTI's intangible assets ($14.8M) and goodwill ($3.0M) from INVO's balance sheet."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-014019","json":"https://secwatch.observer/filing/0001641172-25-014019.json","markdown":"https://secwatch.observer/filing/0001641172-25-014019.md","text":"https://secwatch.observer/filing/0001641172-25-014019.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1417926/000164117225014019/0001641172-25-014019-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1417926/000164117225014019/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T18:15:33.360069+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0607ed9cab2a3cce94fe88ba344797ecc8bc9f84","claim":"INVO Fertility, Inc. completed a disposition (closed 2025-06-02).","evidence_excerpt":"Effective June 2, 2025, INVO Fertility, Inc., a Nevada corporation (the “ Company ”) consummated the divestiture of a majority of its holdings in NAYA Therapeutics Inc., a Delaware Corporation (“ NTI ”).","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1417926/000164117225014019/0001641172-25-014019-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"disposition"},{"label":"Closing","value":"2025-06-02"}],"fact_type":"ma_transaction"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}